# VERTEX PHARMACEUTICA (VRTX) — Q1-2009 Earnings Results

**Report date:** 2009-04-16 (after market close)  
**Sector:** Health Care / Biotechnology  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/VRTX/earnings/Q1-2009

## Post-Earnings Brief

### Headline

Vertex Pharmaceuticals Misses on Revenue, Stock Up 2.85%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.82 | N/A | +2.03% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Unknown

No transcript is on record, and the analysis is based solely on numerical results.

### Guidance Changes

No guidance data is available for this quarter.

### What It Means

Vertex Pharmaceuticals reported an EPS of $-0.82, which was slightly better than expected, leading to a stock increase of 2.85%. However, no revenue figures were provided, leaving investors without a complete picture of the company's performance. The lack of guidance and management commentary may lead to uncertainty among investors moving forward.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/VRTX/earnings/Q1-2009_